Sinovac, Sinopharm Beijing and Covaxin will be added to the list of approved vaccines
The UK government has unveiled plans to recognise vaccines on the World Health Organisation’s (WHO) Emergency Use Listing, already followed by US regulation-makers.
As a result, Sinovac, Sinopharm Beijing and Covaxin will be added to the list of approved vaccines for inbound travel.
The new directive, which will come into effect on 22 November 2022, will open borders for many travellers from countries such as the UAE, Malaysia and India where Sinopharm has been widely administered.
Passengers who have been fully vaccinated and hold a vaccine certificate from one of more than 135 approved countries and territories are not required to take a pre-departure test or a day eight test, or self-isolate upon arrival. Instead, these passengers will only need to purchase a lateral flow test to take on their second day after arrival.
Around one billion doses of Sinovac, Sinopharm Beijing and Covaxin vaccines have been delivered worldwide.
For more information, visit www.who.int